MEDP FY 2019 Earnings Report — Medpace Holdings, Inc. Revenue & Financial Results | Market Cap Arena

Medpace Holdings, Inc.MEDP

FY 2019 Earnings

Reported February 25, 2020

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2019	Prior Q	FY 2018	QoQ Change	YoY Change
Revenue	$861M	—	$705M	—	22.2%
Op. Income	$127M	—	$101M	—	25.9%
Gross Margin	28.5%	—	30.6%	—	-2.1pp
Net Margin	11.7%	—	10.4%	—	1.3pp
EPS (Diluted)	$2.67	—	$1.97	—	35.5%
Free Cash Flow	$184M	—	$141M	—	30.9%

Revenue Flow

Item	Amount
REVENUE	$861M
Cost of Revenue	$615M
GROSS PROFIT	$246M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$95M
Other Expenses	$23M
Operating Expenses	$118M
Cost & Expenses	$734M
OPERATING INCOME	$127M
Interest Income	$0
Interest Expense	$2M
Other Income/Expenses	-$2M
INCOME BEFORE TAX	$125M
Income Tax Expense	$24M
Net Income from Continuing Ops	$100M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$100M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$100M
D&A	$23M
EBIT	$127M
EBITDA	$150M
EPS	$3
EPS Diluted	$3

Income Statement

Item	Amount
REVENUE	$861M
Cost of Revenue	$615M
GROSS PROFIT	$246M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$95M
Other Expenses	$23M
Operating Expenses	$118M
Cost & Expenses	$734M
OPERATING INCOME	$127M
Interest Income	$0
Interest Expense	$2M
Other Income/Expenses	-$2M
INCOME BEFORE TAX	$125M
Income Tax Expense	$24M
Net Income from Continuing Ops	$100M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$100M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$100M
D&A	$23M
EBIT	$127M
EBITDA	$150M
EPS	$3
EPS Diluted	$3

Cash Flow Statement

Item	Amount
Net Income	$100M
Depreciation & Amortization	$23M
Stock-Based Compensation	$21M
Deferred Income Tax	$10M
Other Non-Cash Items	$12M
Change in Working Capital	$36M
OPERATING CASH FLOW	$202M
Capital Expenditure	-$18M
Acquisitions (Net)	$0
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	-$1M
NET CASH FROM INVESTING	-$19M
Net Debt Issuance	-$80M
Common Stock Repurchased	$0
Common Dividends Paid	$0
Other Financing Activities	$7M
NET CASH FROM FINANCING	-$74M
FREE CASH FLOW	$184M
Net Change in Cash	$109M

Balance Sheet

Item	Amount
Cash & Equivalents	$132M
Short-Term Investments	$0
Net Receivables	$156M
Inventory	$0
Other Current Assets	$0
TOTAL CURRENT ASSETS	$317M
PP&E (Net)	$99M
Goodwill	$662M
Intangible Assets	$54M
Long-Term Investments	$0
Tax Assets	$376.0K
Other Non-Current Assets	$9M
TOTAL NON-CURRENT ASSETS	$826M
TOTAL ASSETS	$1.1B
Account Payables	$22M
Short-Term Debt	$0
Deferred Revenue	$192M
Other Current Liabilities	$53M
TOTAL CURRENT LIABILITIES	$343M
Long-Term Debt	$0
Deferred Revenue NC	$0
Deferred Tax Liabilities	$13M
Other Non-Current Liabilities	$16M
TOTAL NON-CURRENT LIABILITIES	$74M
TOTAL LIABILITIES	$417M
Common Stock	$360.0K
Additional Paid-In Capital	$667M
Retained Earnings	$68M
Treasury Stock	-$6M
Accum. Other Comp. Income	-$3M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$726M
Minority Interest	$0
TOTAL EQUITY	$726M
TOTAL LIABILITIES & EQUITY	$1.1B
Total Debt	$45M
Net Debt	-$87M